Heparin sodium
Heparin Sodium is an injectable anticoagulant medication used to prevent blood clots. It comes in strengths of 1,000, 5,000, or 10,000 units per mL and is administered intravenously or subcutaneously. Manufactured by Hospira, Inc., it's a prescription drug available as a generic. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Heparin Sodium is an injectable anticoagulant medication used to prevent blood clots. It comes in strengths of 1,000, 5,000, or 10,000 units per mL and is administered intravenously or subcutaneously. Manufactured by Hospira, Inc., it's a prescription drug available as a generic. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Heparin sodium",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Heparin sodium — ANDA 019339 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019339"
}
]
|
| identifier | ANDA019339 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-safety",
"fda",
"health-care"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Heparin sodium |
